CTMX logo

CytomX Therapeutics (CTMX)

Profile

Full Name

CytomX Therapeutics, Inc.

Ticker Symbol

CTMX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 8, 2015

Indexes

Not included

Website

http://www.cytomx.com

Employees

119

Key Details

Price

$0.66(+4.13%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$138.10M(+36.45% YoY)

Annual EPS

$0.38(+3900.00% YoY)

PE ratio

1.68

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.66
CTMX price is $0.66

30-Day Relative Volume

0.19
CTMX 30-day relative volume is 0.19

Price Performance

Price Today change

+4.13%
CTMX price is up +4.13% today

Price YTD change

-36.31%
CTMX price is down -36.31% since January 1st

Price 1-year change

-62.73%
CTMX price is down -62.73% year-on-year

Price 3-year change

-71.6%
CTMX price is down -71.6% over the past 3 years

Price Range

Price All-time high

$35.00
CTMX price is currently -98.13% below its historical high of $35.00

Price 3-year low

$0.40
CTMX price is currently +64.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$52.55M
CTMX market capitalization is $52.55 million

Market cap 3-year change

-65.22%
CTMX market capitalization is down -65.22% over the past 3 years

Market cap All-time high

$1.32B
CTMX market capitalization is currently -96.02% below its historical high of $1.32 billion

Market cap sector rank

38.57%
CTMX market capitalization is higher than 38.57% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+17.56%
CTMX shares outstanding is up +17.56% year-on-year

Shares Outstanding 3-Year Change

+22.48%
CTMX shares outstanding is up +22.48% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.05
CTMX beta is 1.05

200-day SMA

$1.01
CTMX price is currently -35.20% below its 200-day simple moving average

50-day SMA

$0.66
CTMX price is currently +0.02% above its 50-day simple moving average

RSI

56.91
CTMX 14-day relative strength index is 56.91

Volume

0.19
CTMX 30-day relative volume is 0.19

ATR

$0.06
CTMX average true range is $0.06

10-day Historical Volatility

134.22%
CTMX 10-day historical volatility is 134.22%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$138.10M
CTMX annual revenue is $138.10 million

Revenue Analysts estimate

$106.08M
CTMX annual revenue is currently +30.19% higher than the consensus analysts' forecast

Revenue 1-year change

+36.45%
CTMX annual revenue is up +36.45% year-on-year

Revenue Sector rank

59.69%
CTMX annual revenue is higher than 59.69% of companies in Healthcare sector

EPS

EPS

$0.38
CTMX annual earnings per share is $0.38

EPS Analysts estimate

$0.18
CTMX annual earnings per share is currently +111.58% higher than the consensus analysts' forecast

EPS 1-year change

+3900%
CTMX annual earnings per share is up +3900% year-on-year

EPS Sector rank

86.36%
CTMX annual earnings per share is higher than 86.36% of companies in Healthcare sector

Profit

Gross profit

-
CTMX annual gross profit value is unknown

Gross margin

-
CTMX annual gross profit margin value is unknown

Operating profit

$25.00M
CTMX annual operating income is $25.00 million

Operating margin

18.10%
CTMX annual operating profit margin is 18.10%

Net income

$31.87M
CTMX annual net profit is $31.87 million

Net margin

23.08%
CTMX annual net profit margin is 23.08%

Expenses

Total expenses

$113.11M
CTMX annual total expenses is $113.11 million

Operating expenses

$113.11M
CTMX annual total operating expenses is $113.11 million

Cost of goods sold

-
CTMX annual cost of goods sold value is unknown

Selling, general & administrative expenses

$29.73M
CTMX annual SGA is $29.73 million

Depreciation and amortization

$1.77M
CTMX annual depreciation & amortization is $1.77 million

Interest expense

-
CTMX annual interest expense value is unknown

Income tax

$224.00K
CTMX annual income tax is $224.00 thousand

EBIT & EBITDA

EBIT

$25.00M
CTMX annual earnings before interest & taxes is $25.00 million

EBITDA

$26.76M
CTMX annual EBITDA is $26.76 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$120.53M
CTMX annual total assets is $120.53 million

Non current assets

$13.23M
CTMX annual long term assets is $13.23 million

Current assets

$107.31M
CTMX annual total current assets is $107.31 million

Cash and cash equivalents

$38.05M
CTMX annual cash & cash equivalents is $38.05 million

Accounts receivable

$3.10M
CTMX annual accounts receivable is $3.10 million

Inventory

-
CTMX annual inventory value is unknown

Liabilities

Total liabilities

$120.99M
CTMX annual total liabilities is $120.99 million

Long term liabilities

$35.22M
CTMX annual total long term liabilities is $35.22 million

Current liabilities

$85.77M
CTMX annual total current liabilities is $85.77 million

Accounts payable

$1.09M
CTMX annual accounts payable is $1.09 million

Debt

Total debt

$9.38M
CTMX annual total debt is $9.38 million

Total debt 1-year change

-32.84%
CTMX annual total debt is down -32.84% year-on-year

Long term debt

$4.24M
CTMX annual long term debt is $4.24 million

Short term debt

$5.14M
CTMX annual short term debt is $5.14 million

Equity & Capital

Shareholders equity

-$456.00K
CTMX annual stockholders equity is -$456.00 thousand

Book value

-$456.00K
CTMX annual book value is -$456.00 thousand

Retained earnings

-$691.58M
CTMX annual retained earnings is -$691.58 million

Working capital

$21.53M
CTMX annual working capital is $21.53 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$86.23M
CTMX annual cash flow from operations is -$86.23 million

Cash from operations 1-year change

-53.89%
CTMX annual cash flow from operations is down -53.89% year-on-year

Cash from investing

$99.70M
CTMX annual cash flow from investing activities is $99.70 million

Cash from investing 1-year change

+166.17%
CTMX annual cash flow from investing activities is up +166.17% year-on-year

Cash from financing

$7.52M
CTMX annual cash flow from financing activities is $7.52 million

Cash from financing 1-year change

-75.12%
CTMX annual cash flow from financing activities is down -75.12% year-on-year

CAPEX

CAPEX

$310.00K
CTMX annual capital expenditures is $310.00 thousand

CAPEX 1-year change

-63.1%
CTMX annual capital expenditures is down -63.1% year-on-year

Free Cash Flow

Free cash flow

-$86.54M
CTMX annual free cash flow is -$86.54 million

Free cash flow 1-year change

-52.16%
CTMX annual free cash flow is down -52.16% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
CTMX annual gross profit margin value is unknown

Operating margin

18.10%
CTMX annual operating profit margin is 18.10%

Net margin

23.08%
CTMX annual net profit margin is 23.08%

ROA & ROE

ROA

19.77%
CTMX annual return on assets is 19.77%

ROE

-6988.82%
CTMX annual return on equity is -6988.82%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

1.68
CTMX price to earnings ratio is 1.68

PE ratio Sector rank

2.94%
CTMX price to earnings ratio is higher than 2.94% of companies in Healthcare sector

PB Ratio

PB ratio

-115.23
CTMX price to book ratio is -115.23

PB ratio Sector rank

0.08%
CTMX price to book ratio is higher than 0.08% of companies in Healthcare sector

PS Ratio

PS ratio

0.38
CTMX price to sales ratio is 0.38

PS ratio Sector rank

13.21%
CTMX price to sales ratio is higher than 13.21% of companies in Healthcare sector

Enterprise value

Enterprise value

$23.88M
CTMX enterprise value is $23.88 million

Enterprise value Sector rank

33.28%
CTMX enterprise value is higher than 33.28% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.89
CTMX EV/EBITDA is 0.89

EV/EBITDA Sector rank

74.52%
CTMX EV/EBITDA is higher than 74.52% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.25
CTMX annual current ratio is 1.25

Quick ratio

-
CTMX annual quick ratio value is unknown

Leverage

Debt to equity

0.00
CTMX annual debt to equity ratio is 0.00

Interest coverage ratio

-
CTMX annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
CTMX piotroski f-score value is unknown

Altman Z-Score

-5.73
CTMX altman z-score is -5.73

Analyst ratings

Recent major analysts updates

Apr 14, 25 Piper Sandler
Overweight
Mar 7, 25 HC Wainwright & Co.
Neutral
Jan 7, 25 HC Wainwright & Co.
Neutral
Nov 11, 24 HC Wainwright & Co.
Neutral
Sep 13, 24 HC Wainwright & Co.
Neutral
Aug 22, 24 HC Wainwright & Co.
Neutral
Jun 27, 24 HC Wainwright & Co.
Neutral
May 28, 24 Piper Sandler
Overweight
May 9, 24 Wedbush
Outperform
May 9, 24 HC Wainwright & Co.
Neutral

Institutional Ownership

Similar stocks

ATHE logo
Alterity Therapeutics Limited (ATHE)
BYSI logo
BeyondSpring (BYSI)
ALVR logo
AlloVir (ALVR)
AVTX logo
Avalo Therapeutics (AVTX)
ONCY logo
Oncolytics Biotech (ONCY)
ICCC logo
ImmuCell (ICCC)
VNRX logo
VolitionRx Limited (VNRX)
VTVT logo
vTv Therapeutics (VTVT)
PMVP logo
PMV Pharmaceuticals (PMVP)
  • What is the ticker symbol for CytomX Therapeutics?
  • Does CytomX Therapeutics pay dividends?
  • What sector is CytomX Therapeutics in?
  • What industry is CytomX Therapeutics in?
  • What country is CytomX Therapeutics based in?
  • When did CytomX Therapeutics go public?
  • Is CytomX Therapeutics in the S&P 500?
  • Is CytomX Therapeutics in the NASDAQ 100?
  • Is CytomX Therapeutics in the Dow Jones?
  • When was CytomX Therapeutics's last earnings report?
  • When does CytomX Therapeutics report earnings?
  • Should I buy CytomX Therapeutics stock now?

What is the ticker symbol for CytomX Therapeutics?

The ticker symbol for CytomX Therapeutics is NASDAQ:CTMX

Does CytomX Therapeutics pay dividends?

No, CytomX Therapeutics does not pay dividends

What sector is CytomX Therapeutics in?

CytomX Therapeutics is in the Healthcare sector

What industry is CytomX Therapeutics in?

CytomX Therapeutics is in the Biotechnology industry

What country is CytomX Therapeutics based in?

CytomX Therapeutics is headquartered in United States

When did CytomX Therapeutics go public?

CytomX Therapeutics's initial public offering (IPO) was on October 8, 2015

Is CytomX Therapeutics in the S&P 500?

No, CytomX Therapeutics is not included in the S&P 500 index

Is CytomX Therapeutics in the NASDAQ 100?

No, CytomX Therapeutics is not included in the NASDAQ 100 index

Is CytomX Therapeutics in the Dow Jones?

No, CytomX Therapeutics is not included in the Dow Jones index

When was CytomX Therapeutics's last earnings report?

CytomX Therapeutics's most recent earnings report was on Mar 6, 2025

When does CytomX Therapeutics report earnings?

The next expected earnings date for CytomX Therapeutics is May 8, 2025

Should I buy CytomX Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page